The pattern of atrophy in familial alzheimer disease: Volumetric MRI results from the DIAN study

Neurology

Volumn 81, Issue 16, 2013, Pages 1425-1433

  Cash, David M ^a   Ridgway, Gerard R ^a   Liang, Yuying ^a   Ryan, Natalie S ^a   Kinnunen, Kirsi M ^a   Yeatman, Thomas ^a   Malone, Ian B ^a   Benzinger, Tammie L S ^b   Jack Jr , Clifford R ^c   Thompson, Paul M ^d   Ghetti, Bernardino F ^e   Saykin, Andrew J ^e   Masters, Colin L ^f   Ringman, John M ^d   Salloway, Stephen P ^g   Schofield, Peter R ^h   Sperling, Reisa A ⁱ   Cairns, Nigel J ^b   Marcus, Daniel S ^b   Xiong, Chengjie ^b   Bateman, Randall J ^b   Morris, John C ^b   Rossor, Martin N ^a   Ourselin, Sébastien ^a   Fox, Nick C ^a   more..

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g BUTLER HOSPITAL   (United States)

^h NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

ⁱ BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; PRESENILIN 1; PRESENILIN 2;

ADULT; ALZHEIMER DISEASE; ARTICLE; ATROPHY; CINGULATE GYRUS; CLINICAL ASSESSMENT; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENETIC SCREENING; GENOTYPE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRECUNEUS; PRIORITY JOURNAL; PUTAMEN; TEMPORAL LOBE; THALAMUS; WHITE MATTER;

ADULT; AGE OF ONSET; ALZHEIMER DISEASE; ATROPHY; CEREBRAL CORTEX; CEREBRUM; COHORT STUDIES; FEMALE; HETEROZYGOTE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PRODROMAL SYMPTOMS; PROGNOSIS; YOUNG ADULT;

EID: 84888264549     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182a841c6     Document Type: Article

References (38)

1. Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G. Effect of tarenflurbil on cognitive decline and activities of daily living. JAMA 2009;302:2557-2564.
2. Sampson K., Phase I Alzheimer trial halted: search for therapeutic biomarkers continues. Ann Neurol 2010;68: A9-A12.
3. Golde TE, Schneider LS, Koo EH. Anti-ab therapeutics in Alzheimer's disease: The need for a paradigm shift. Neuron 2011;69:203-213.
4. Sperling RA, Jack CR, Aisen PS. Testing the right target and right drug at the right stage. Sci Transl Med 2011;3: 111cm33.
5. Bateman RJ, Aisen PS, De Strooper B, Fox NC, Lemere CA, Ringman JM. Autosomal-dominant Alzheimer's disease: A review and proposal for the prevention of Alzheimer's disease. Alzheimers Res Ther 2011;3:1-13.
6. Reiman EM, Langbaum JB, Fleisher AS, et al. Alzheimer's Prevention Initiative: A plan to accelerate the evaluation of presymptomatic treatments. J Alzheimers Dis 2011;26 (suppl 3):321-329.
7. Knight WD, Okello AA, Ryan NS, et al. Carbon-11- Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers. Brain 2011;134:293-300.
8. Klunk WE, Price JC, Mathis CA, et al. Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci 2007;27:6174-6184.
9. Bateman RJ, Xiong C, Benzinger TL, et al. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 2012;367:795-804.
10. Fox NC, Warrington EK, Freeborough PA, Hartikainen P, Kennedy AM. Presymptomatic hippocampal atrophy in Alzheimer's disease: A longitudinal MRI study. Brain 1996; 119:2001-2007.
11. Schott JM, Fox NC, Frost C, et al. Assessing the onset of structural change in familial Alzheimer's disease. Ann Neurol 2003;53:181-188.
12. Knight WD, Kim LG, Douiri A, Frost C, Rossor MN, Fox NC. Acceleration of cortical thinning in familial Alzheimer's disease. Neurobiol Aging 2011;32:1765-1773.
13. Fortea J, Sala-Llonch R, Bartrés-Faz D, et al. Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers. J Alzheimers Dis 2010;22: 909-922.
14. Lee GJ, Lu PH, Medina LD, et al. Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations. J Neurol Neurosurg Psychiatry 2013;84:154-162.
15. Quiroz YT, Stern CE, Reiman EM, et al. Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers. J Neurol Neurosurg Psychiatry 2013;84: 556-561.
16. Apostolova LG, Hwang KS, Medina LD, et al. Cortical and hippocampal atrophy in patients with autosomal dominant familial Alzheimer's disease. Dement Geriatr Cogn Disord 2011;32:118-125.
17. Reiman EM, Quiroz YT, Fleisher AS, et al. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: A case-control study. Lancet Neurol 2012;11:1048-1056.
18. Morris JC, Aisen PS, Bateman RJ, et al. Developing an international network for Alzheimer research: The dominantly inherited Alzheimer network. Clin Invest 2012;2: 975-984.
19. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-2414.
20. Jack CR, Bernstein MA, Borowski BJ, et al. Update on the magnetic resonance imaging core of the Alzheimer's Disease Neuroimaging Initiative. Alzheimers Dement 2010;6: 212-220.
21. Jack CR, Bernstein MA, Fox NC, et al. The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 2008;27:685-691.
22. Ashburner J. A fast diffeomorphic image registration algorithm. Neuroimage 2007;38:95-113.
23. Ridgway GR, Omar R, Ourselin S, Hill DLG, Warren JD, Fox NC. Issues with threshold masking in voxel-based morphometry of atrophied brains. Neuroimage 2009;44: 99-111.
24. Gutiérrez-Galve L, Lehmann M, Hobbs NZ, et al. Patterns of cortical thickness according to APOE genotype in Alzheimer's disease. Dement Geriatr Cogn Disord 2009; 28:476-485.
25. Jagust W., Apolipoprotein E, neurodegeneration, and Alzheimer disease. Arch Neurol 2012;70:1-2.
26. Kriegeskorte N, Lindquist MA, Nichols TE, Poldrack RA, Vul E. Everything you never wanted to know about circular analysis, but were afraid to ask. J Cereb Blood Flow Metab 2010;30:1551-1557.
27. De Jong LW, Van der Hiele K, Veer IM, et al. Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: An MRI study. Brain 2008;131:3277-3285.
28. Fjell AM, Walhovd KB, Fennema-Notestine C, et al. One-year brain atrophy evident in healthy aging. J Neurosci 2009;29:15223-15231.
29. Ryan NS, Keihaninejad S, Shakespeare TJ, et al. MRI evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease. Brain 2013;136: 1399-1414.
30. Wirth M, Madison CM, Rabinovici GD, Oh H, Landau SM, Jagust WJ. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not -amyloid in cognitively normal older individuals. J Neurosci 2013;33:5553-5563.
31. Desikan RS, McEvoy LK, Thompson WK, et al. Amyloidb- Associated clinical decline occurs only in the presence of elevated p-tau. Arch Neurol 2012;69:709-713.
32. Fjell AM, Walhovd KB. Neuroimaging results impose new views on Alzheimer's disease: The role of amyloid revised. Mol Neurobiol 2012;45:153-172.
33. Ringman JM, O'Neill J, Geschwind D, et al. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations. Brain 2007;130: 1767-1776.
34. Ryan NS, Rossor MN. Correlating familial Alzheimer's disease gene mutations with clinical phenotype. Biomark Med 2010;4:99-112.
35. Scahill RI, Ridgway GR, Bartlett JW, et al. Genetic influences on atrophy patterns in familial Alzheimer's disease: A comparison of APP and PSEN1 mutations. J Alzheimers Dis 2013;35:199-212.
36. Chávez-Gutiérrez L, Bammens L, Benilova I, et al. The mechanism of g-secretase dysfunction in familial Alzheimer disease. EMBO J 2012;31:2261-2274.
37. Gessel MM, Bernstein S, Kemper M, Teplow DB, Bowers MT. Familial Alzheimer's disease mutations differentially alter amyloid b-protein oligomerization. ACS Chem Neurosci 2012;3:909-918.
38. Shepherd C, McCann H, Halliday GM. Variations in the neuropathology of familial Alzheimer's disease. Acta Neuropathol 2009;118:37-52.